Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Adenocarcinoma × Liquid Biopsy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 9 Colorectal Neoplasms 8 Lung Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Pancreatic Neoplasms 5 Neoplastic Cells, Circulating 4 Neoplasm Metastasis 4 Biliary Tract Neoplasms 4 Recurrence 3 Prostatic Neoplasms 3 Oropharyngeal Neoplasms 3 Neoplasm, Residual 3 Disease 3 Squamous Cell Carcinoma of Head and Neck 2 Nevi and Melanomas 2 Neuroendocrine Tumors 2 Nasopharyngeal Carcinoma 2 Melanoma 2 Head and Neck Neoplasms 2 Cholangiocarcinoma 2 Carcinoma, Hepatocellular 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Smoking 1 Sarcoma, Ewing 1 Salivary Gland Neoplasms 1

Interventions

Oxaliplatin 31 Fluorouracil 23 Gemcitabine 19 Leucovorin 18 Docetaxel 18 pembrolizumab 17 Capecitabine 15 Radiotherapy 13 Irinotecan 13 Bevacizumab 11 Cisplatin 10 Nivolumab 8 130-nm albumin-bound paclitaxel 8 Cyclophosphamide 7 Trastuzumab 6 Radiosurgery 6 Paclitaxel 6 Albumin-Bound Paclitaxel 6 S 1 (combination) 5 Metformin 5 Erlotinib Hydrochloride 5 Carboplatin 5 Blood Specimen Collection 5 Taxes 4 Sunitinib 4 Sorafenib 4 Pemetrexed 4 Esophagectomy 4 Chemoradiotherapy 4 Cetuximab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06090214 2023-10-19

BLADE

University Hospital, Montpellier

Phase NA Unknown

Adenocarcinoma, Neoplastic Cells, Circulating

Data powered by HemOnc (CC BY 4.0) Colophon ⚡